Bayer shares (XE:BAYN) slumped 8% in early Frankfurt trade as the company said the agricultural market was weaker than expected and that it's facing pricing pressure in crop protection. It lowered its EBITDA before special items forecast to a range of EUR10.4 billion to EUR10.7 billion, from EUR10.7 billion to EUR11.3 billion, and Bayer said it is cautious on the agricultural market environment for 2025. Bayer did say its pharma business will deliver at the upper end of its 2024 guidance.
-Steve Goldstein
For more from MarketWatch: http://www.marketwatch.com/newsviewer
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
November 12, 2024 03:07 ET (08:07 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.
Comments